NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Fosfomycin and Iron: what the published research says

PubMed indexes 3 records that name Fosfomycin and Iron together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Fosfomycin and Iron. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

3 studies naming Fosfomycin and Iron.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Evidence that the fosfomycin-producing epoxidase, HppE, is a non-heme-iron peroxidase.

Science (New York, N.Y.) · 2013 · PMID 24114783

Research Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, Non-P.H.S.

“Reaction with H2O2 is accelerated by bound substrate and produces fosfomycin catalytically with a stoichiometry of unity. The ability of catalase to suppress the HppE activity previously attributed to its direct utilization of O2 implies that reduction of O2 and utilization of the resultant H2O2 were actually operant.”

Wang et al. · From the abstract

Names both Fosfomycin and Iron in its title.

Structural basis of regiospecificity of a mononuclear iron enzyme in antibiotic fosfomycin biosynthesis.

Journal of the American Chemical Society · 2011 · PMID 21682308

Research Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, Non-P.H.S.

“To probe the mechanism of HppE regiospecificity, we determined three X-ray structures: R-HPP with inert cobalt-containing enzyme (Co(II)-HppE) at 2.1 Å resolution; R-HPP with active iron-containing enzyme (Fe(II)-HppE) at 3.0 Å resolution; and S-HPP-Fe(II)-HppE in complex with dioxygen mimic NO at 2.9 Å resolution.”

Yun et al. · From the abstract

Names both Fosfomycin and Iron in its title.

Structural insight into antibiotic fosfomycin biosynthesis by a mononuclear iron enzyme.

Nature · 2005 · PMID 16015285

Research Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, Non-P.H.S.

“These structural data lead us to suggest how this enzyme is able to recognize and respond to its substrate with a conformational change that protects the radical-based intermediates formed during catalysis. Comparisons with other family members suggest why substrate binding is able to prime iron for dioxygen binding in the absence of alpha-ketoglutarate (a co-substrate required by many mononuclear iron enzymes), and how the unique epoxidation reaction of…”

Higgins et al. · From the abstract

Names both Fosfomycin and Iron in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Fosfomycin, Iron, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.